• Globe Newswire

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

Globenewswire -

• Globe Newswire

AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer

Globenewswire -

• Globe Newswire

Winners in First Annual Stevie® Awards for Technology Excellence Announced

• Globe Newswire

Olon Group Announces the Acquisition of GTP Bioways Group

• Globe Newswire

Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women

[img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=f83bbfc7-6e0b-45d2-9685-2250a8861042&size=3[/img]

• Globe Newswire

Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024

• Globe Newswire

AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001 Administration in Patients with Nonmelanoma Skin Cancer